Monocytes and neutrophils as ‘bad guys’ for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma – results from a randomised phase II trial
Frede Donskov(Aarhus University Hospital), Hans von der Maase(Aarhus University Hospital)
Cited by 71
Related Papers
Impact of Immune Parameters on Long-Term Survival in Metastatic Renal Cell Carcinoma
|Journal of Clinical Oncology|2006|308
Tumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer
|British Journal of Cancer|2013|131
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials
|Current Oncology Reports|2025|20